Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
US10208081B2 · kind B2 · utility
9Cited by
4References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2015 |
| Grant date | Feb 19, 2019 |
| Priority date | — |
| Expiry date | Nov 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J51/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.